Ligand validation:3I27

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3I27 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3I27_NAG_D_5156	40%	46%	0.167	0.876	0.44	1.61	-	3	0	0	100%	1
3I27_NAG_A_5156	24%	39%	0.23	0.858	0.78	1.59	1	4	0	0	100%	1
3I27_NAG_D_5157	22%	65%	0.235	0.852	0.54	0.8	-	-	0	0	100%	1
3I27_NAG_A_5157	7%	59%	0.38	0.837	0.49	1.06	-	1	0	0	100%	1
3I27_NAG_B_5154	2%	50%	0.417	0.717	0.66	1.25	-	2	1	0	100%	1
3I26_NAG_D_5157	27%	55%	0.225	0.875	0.5	1.2	-	1	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.